SPA
HCAT icon

Sherbrooke Park Advisers’s Health Catalyst HCAT Stock Holding History

Sherbrooke Park Advisers’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,244
Closed -$43.4K – 357
2025
Q3 		$43.4K Buy
15,244
+2,298
+18% +$7.87K 0.02% 495
2025
Q2 		$48.8K Sell
12,946
-26,590
-67% -$105K 0.02% 500
2025
Q1 		$179K Buy
39,536
+5,439
+16% +$28.8K 0.08% 440
2024
Q4 		$241K Sell
34,097
-14,173
-29% -$113K 0.08% 504
2024
Q3 		$393K Buy
48,270
+28,138
+140% +$203K 0.09% 435
2024
Q2 		$129K Buy
20,132
+5,506
+38% +$35.3K 0.02% 814
2024
Q1 		$110K Buy
14,626
+3,633
+33% +$33.2K 0.02% 788
2023
Q4 		$102K Buy
+10,993
New +$89.8K 0.05% 400

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sherbrooke Park Advisers's HCAT Position: Q4 2025 in Review

Sherbrooke Park Advisers sold out of Health Catalyst (HCAT) in Q4 2025, closing a stake of 15,244 shares — an estimated $43.4K sold.

Sherbrooke Park Advisers first reported a position in HCAT in Q4 2023 and held it in 8 quarters. The position peaked at $393K in Q3 2024. 136 funds tracked by Wall St. Rank hold HCAT as of Q4 2025.

  • Sherbrooke Park Advisers reported no remaining Health Catalyst position as of Q4 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 15,244 Health Catalyst shares in Q4 2025, an estimated $43.4K.
  • Sherbrooke Park Advisers first reported a position in Health Catalyst in Q4 2023 and held it in 8 quarters.
  • Sherbrooke Park Advisers's Health Catalyst position peaked at $393K in Q3 2024.
  • 136 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.